|  | Group A | Group B | P Value |
---|---|---|---|---|
Pre-op | PF | 64.0 ± 5.3 | 65.4 ± 6.3 | 0.259 |
RP | 14.7 ± 13.7 | 15.1 ± 16.1 | 0.912 | |
BP | 43.5 ± 8.6 | 41.6 ± 9.0 | 0.305 | |
GH | 26.4 ± 14.6 | 24.6 ± 11.9 | 0.538 | |
VT | 45.6 ± 11.0 | 44.8 ± 11.7 | 0.729 | |
SF | 27.9 ± 9.3 | 26.6 ± 8.0 | 0.495 | |
RE | 35.9 ± 16.0 | 34.0 ± 16.1 | 0.591 | |
MH | 29.5 ± 11.5 | 31.0 ± 11.5 | 0.532 | |
Post-op 5th Year | PF* | 81.1 ± 5.9 | 82.9 ± 5.6 | 0.152 |
RP* | 88.0 ± 15.5 | 92.3 ± 14.2 | 0.186 | |
BP* | 86.0 ± 6.6 | 87.2 ± 7.2 | 0.420 | |
GH* | 80.0 ± 12.5 | 81.8 ± 13.3 | 0504 | |
VT* | 88.1 ± 6.1 | 78.8 ± 8.7 | 0.211 | |
SF* | 76.6 ± 7.6 | 86.6 ± 5.1 | 0.194 | |
RE* | 88.8 ± 15.9 | 89.7 ± 15.6 | 0.802 | |
MH* | 82.1 ± 9.4 | 84.1 ± 11.6 | 0.374 |